These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 22753261)
1. Identification of novel driver tumor suppressors through functional interrogation of putative passenger mutations in colorectal cancer. Zhang L; Komurov K; Wright WE; Shay JW Int J Cancer; 2013 Feb; 132(3):732-7. PubMed ID: 22753261 [TBL] [Abstract][Full Text] [Related]
2. Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth. Eskiocak U; Kim SB; Ly P; Roig AI; Biglione S; Komurov K; Cornelius C; Wright WE; White MA; Shay JW Cancer Res; 2011 Jul; 71(13):4359-65. PubMed ID: 21527559 [TBL] [Abstract][Full Text] [Related]
3. Exome Sequencing of Normal and Isogenic Transformed Human Colonic Epithelial Cells (HCECs) Reveals Novel Genes Potentially Involved in the Early Stages of Colorectal Tumorigenesis. Zhang L; Kim S; Jia G; Buhmeida A; Dallol A; Wright WE; Fornace AJ; Al-Qahtani M; Shay JW BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S8. PubMed ID: 25923178 [TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of Cytolethal Distending Toxin (CDT) on Isogenic Human Colorectal Cell Lines: Potential Promoting Effects for Colorectal Carcinogenesis. Graillot V; Dormoy I; Dupuy J; Shay JW; Huc L; Mirey G; Vignard J Front Cell Infect Microbiol; 2016; 6():34. PubMed ID: 27047802 [TBL] [Abstract][Full Text] [Related]
5. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling. Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159 [TBL] [Abstract][Full Text] [Related]
6. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia. Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162 [TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. Russo A; Bazan V; Agnese V; Rodolico V; Gebbia N Ann Oncol; 2005 May; 16 Suppl 4():iv44-49. PubMed ID: 15923428 [TBL] [Abstract][Full Text] [Related]
8. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012 [TBL] [Abstract][Full Text] [Related]
9. Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo. Derouet M; Wu X; May L; Hoon Yoo B; Sasazuki T; Shirasawa S; Rak J; Rosen KV Neoplasia; 2007 Jul; 9(7):536-45. PubMed ID: 17710156 [TBL] [Abstract][Full Text] [Related]
10. Impact of Cellular Genetic Make-up on Colorectal Cancer Cell Lines Response to Ellagic Acid: Implications of Small Interfering RNA. Yousef AI; El-Masry OS; Abdel Mohsen MA Asian Pac J Cancer Prev; 2016; 17(2):743-8. PubMed ID: 26925673 [TBL] [Abstract][Full Text] [Related]
11. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer. Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486 [TBL] [Abstract][Full Text] [Related]
12. Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer. Tang J; Li Y; Lyon K; Camps J; Dalton S; Ried T; Zhao S Oncogene; 2014 Feb; 33(7):814-22. PubMed ID: 23416983 [TBL] [Abstract][Full Text] [Related]
13. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development. Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157 [TBL] [Abstract][Full Text] [Related]
14. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation. Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880 [TBL] [Abstract][Full Text] [Related]
16. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo. Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695 [TBL] [Abstract][Full Text] [Related]
17. Mathematical model of colorectal cancer initiation. Paterson C; Clevers H; Bozic I Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20681-20688. PubMed ID: 32788368 [TBL] [Abstract][Full Text] [Related]